Median time to treatment response in patients with moderate-to-severe plaque psoriasis treated with brodalumab 210 mg or ustekinumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

被引：0
|
作者：
Blauvelt, Andrew [1 ]
Lebwohl, Mark [2 ]
Green, Lawrence [3 ]
Hsu, Sylvia [3 ]
Bhatt, Varsha [4 ]
Rastogi, Shipra [5 ]
Israel, Robert [5 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Dept Dermatol, New York, NY USA
[4] Dow Pharmaceut Sci, Petaluma, CA USA
[5] Valeant Pharmacuet, Laval, PQ, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
5092
引用
收藏
页码：AB167 / AB167
页数：1
相关论文
共 50 条
  • [1] Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
    Blauvelt, Andrew
    Papp, Kim A.
    Lebwohl, Mark G.
    Green, Lawrence J.
    Hsu, Sylvia
    Bhatt, Varsha
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) : 372 - 374
  • [2] Rapid onset of efficacy in patients with psoriasis treated with brodalumab versus ustekinumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
    Papp, Kim
    Lebwohl, Mark
    Bhatt, Varsha
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB213 - AB213
  • [3] Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3
    Papp, K. A.
    Gordon, K. B.
    Langley, R. G.
    Lebwohl, M. G.
    Gottlieb, A. B.
    Rastogi, S.
    Pillai, R.
    Israel, R. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 320 - 328
  • [4] Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials
    Amy McMichael
    Seemal R. Desai
    Aamir Qureshi
    Shipra Rastogi
    Andrew F. Alexis
    American Journal of Clinical Dermatology, 2019, 20 : 267 - 276
  • [5] Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials
    McMichael, Amy
    Desai, Seemal R.
    Qureshi, Aamir
    Rastogi, Shipra
    Alexis, Andrew F.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 267 - 276
  • [6] Multistate modelling of probability of on-treatment clinical response and time remaining in response in patients with moderate-to-severe psoriasis treated with brodalumab or ustekinumab in the AMAGINE-2 and -3 studies
    Claus Zachariae
    Ulrich Mrowietz
    Jens Strodl Andersen
    Lluís Puig
    European Journal of Dermatology, 2022, 32 : 530 - 535
  • [7] Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3
    Reich, K.
    Hansen, J. B.
    Puig, L.
    Konstantinou, M. P.
    Warren, R. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : 2034 - 2044
  • [8] Multistate modelling of probability of on-treatment clinical response and time remaining in response in patients with moderate-to-severe psoriasis treated with brodalumab or ustekinumab in the AMAGINE-2 and-3 studies
    Zachariae, Claus
    Mrowietz, Ulrich
    Andersen, Jens Strodl
    Puig, Lluis
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (04) : 530 - 535
  • [9] AMAGINE-3: A phase 3 study of efficacy and safety of brodalumab compared with placebo and ustekinumab in moderate to severe plaque psoriasis subjects
    Strober, Bruce
    Langley, Richard
    Blicharski, Tomasz
    Paul, Carle
    Lacour, Jean-Philippe
    Tyring, Stephen
    Kircik, Leon
    Chimenti, Sergio
    Duffin, Kristina Callis
    Bagel, Jerry
    Koo, John
    Aras, Gary
    Shi, Yifei
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB224 - AB224
  • [10] Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and-3
    Reich, K.
    Iversen, L.
    Puig, L.
    Lambert, J.
    Mrowietz, U.
    Saday, K. Kaplan
    Warren, R. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1275 - 1283
12345